NLRP3 and Cowden disease: In human studies, data have shown that NLRP3 inflammasome expression was stimulated ex vivo in CD patients with a concomitant increase of IL-1β levels in peripheral blood mononuclear cells (PBMCs) in vitro; on the other hand, activation of the NLRP3 was reported in late disease stage of disease in UC patients (58).